Phylogix Inc. is a biotechnology company focused on tissue protection and oncology. The company develops lectin-based drugs focused on tissue protection, oncology, and immunology. It also involves in the development of FRIL, an agent to protect patients from the toxic side-effects of chemotherapy.

Phylogix Inc. is based in Scarborough, Maine.

Overview

Total FundingEmployeesLast Funding DateStatus
$12,000,0002004-03-10Operating

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2004-03-10$12,000,000VentureRadius Ventures, Canaan Partners, Atlas Venture, Prospect Venture PartnersBiotechnology Value Fund